DERM $1.40 may next KALA ...low floater with 11 marketed drugs + one in Phase 3 trials and trading under cash ...Market Cap $24 million / Cash $35 million / Shares Out 17.6 million half of that owned by insiders
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.